Natco Pharma Hits a Grand Slam with US Approval for Drug

Listen up, folks! Natco Pharma just scored a HUGE victory! They got the golden stamp of approval from the US health folks for their generic cancer drug, Erdafitinib. It’s a game-changer, folks, available in 3, 4, and 5 mg. Their stock? Soaring like an eagle, up 3.39%! Tremendous news, simply tremendous! I told you they’d do it!